metricas
covid
Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Tratamiento quirúrgico del hepatocarcinoma en el paciente cirrótico: ¿resecci...
Información de la revista
Vol. 70. Núm. 1.
Páginas 42-48 (julio 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 70. Núm. 1.
Páginas 42-48 (julio 2001)
Acceso a texto completo
Tratamiento quirúrgico del hepatocarcinoma en el paciente cirrótico: ¿resección o trasplante?
Surgical treatment of hepatocarcinoma in cirrhotic patients. Resection or transplantation?
Visitas
7087
J. Santoyo1
Autor para correspondencia
jsantoyo@hch.sas.cica.es

Correspondencia: Dr. J. Santoyo. Servicio de Cirugía General y Digestiva. Hospital Carlos Haya. Av. Carlos Haya, s/n. 29010 Málaga.
, M.A. Suárez, J.L. Fernández, M. Jiménez, C. Ramírez, A. Pérez Daga, J.A. Bondia, A. de la Fuente
Servicio de Cirugía General y Digestiva. Cirugía HBP y Trasplante Hepático. Hospital Carlos Haya. Málaga
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Resumen

La cirrosis es una enfermedad preneoplásica (la probabilidad de desarrollar un hepatocarcinoma a los 5 años es del 20%). El tratamiento curativo del hepatocarcinoma es la exéresis quirúrgica radical mediante resección o trasplante. No existen estudios prospectivos y aleatorizados que comparen la resección frente al trasplante. La supervivencia global a 5 años, con ambas técnicas en casos seleccionados, es superior con el trasplante (60-80%) que con la resección (30-50%). Además, la recurrencia tumoral a largo plazo es muy superior con la resección (70-100%) que con el trasplante (10-20%). En circunstancias ideales de tratamiento (adecuada selección, baja morbimortalidad, disponibilidad de órganos, etc.), el trasplante es una técnica superior, ya que trata simultáneamente la enfermedad tumoral y la enfermedad primaria. No obstante, la recidiva de la enfermedad original (virus C) y los efectos de la inmunosupresión crónica pueden empeorar los resultados a largo plazo.

Palabras clave:
Hepatocarcinoma
Hepatectomía
Trasplante hepático

Cirrhosis is a preneoplastic disease and the probability of developing hepatocarcinoma at 5 years is 20%. Curative treatment of hepatocarcinoma is radical surgical excision through resection or transplantation. No prospective randomized studies comparing resection with transplantation have been published. When these techniques are performed in selected patients, overall 5-year survival is higher with transplantation (60-80%) than with resection (30-50%). Moreover, tumoral recurrence in the long term is much higher with resection (70-100%) than with transplantation (10-20%). When the circumstances of treatment are ideal (appropriate patient selection, low morbidity and mortality, available organs, etc.) transplantation is the superior technique since it treats both the tumoral and the underlying disease simultaneously. Nevertheless, recurrence of the original disease (hepatitis C virus) and the effects of chronic immunosuppression may adversely affect the long-term results.

Key words:
Hepatocarcinoma
Hepatectomy
Liver transplantation
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.X. Bosch, J. Ribes, J. Borrás.
Epidemiology of primary liver cancer.
Sem Liver Dis, 19 (1999), pp. 271-285
[2.]
Registro Español de Trasplante Hepático. Memoria 1999. ONT.
[3.]
D. Farmer, M. Rosove, A. Shaked, R. Busuttil.
Current treatment modalities for hepatocellular carcinoma.
Ann Surg, 219 (1994), pp. 236-247
[4.]
A. Veenok.
Treatment of hepatocellular carcinoma: too many options?.
J Clin Oncol, 12 (1994), pp. 1323-1334
[5.]
W.Y. Lau.
Primary hepatocellular carcinoma.
Surgery of the liverbiliary tract (3.a ed.),
[6.]
J. Bruix.
Treatment of hepatocellular carcinoma.
[7.]
E. Mor, R.T. Kaspa, P. Sheiner, M. Schwartz.
Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation.
Ann Int Med, 129 (1998), pp. 643-653
[8.]
L. Barabara, G. Benzi, S. Gaiani, F. Fusconi, G. Zironi, S. Siringo, et al.
Natural history of untreated small hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.
Hepatology, 16 (1992), pp. 132-137
[9.]
M. Ebara, M. Otho, T. Shinagawa, K. Kimura, S. Matsutani, M. Marita, et al.
Natural history of hepatocellular carcinoma smaller than three centimetres complicating cirrhosis. A study in 22 patients.
Gastroenterology, 90 (1986), pp. 289-298
[10.]
T. Livraghi, L. Bolondi, L. Buscarini, M. Cottone, A. Mazziotti, A. Morabito, et al.
No treatment, resection, and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis.
J Hepatol, 22 (1995), pp. 522-526
[11.]
J. Llovet, J. Bustamante, A. Castells, R. Vilana, M.C. Ayuso, M. Sala, et al.
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutics trials.
Hepatology, 29 (1999), pp. 62-67
[12.]
Z.Y. Tang, Y. Yu, X. Zhou, Z. Ma, R. Yang, J. Lu, et al.
Surgery of small hepatocellular carcinoma. Analysis of 144 cases.
Cancer, 64 (1989), pp. 536-541
[13.]
N. Nagasue, H. Kohno, Y. Chang, H. Taniura, A. Yamanoi, M. Uchida, et al.
Liver resection for hepatocellular carcinoma. Results of a 229 consecutive patients during 11 years.
Ann Surg, 217 (1993), pp. 375-384
[14.]
J. Yamamoto, T. Kosuge, T. Takayama, K. Shimada, H. Yamasaki, H. Ozaqui, et al.
Recurrence of hepatocellular carcinoma.
Br J Surg, 83 (1996), pp. 1219-1222
[15.]
H. Bismuth, D. Houssin, J. Ornowski, F. Merigi.
Liver resection in cirrhotic patients: a western experience.
World J Surg, 10 (1986), pp. 311-317
[16.]
D. Franco, L. Capussotti, C. Smajda, H. Bouzari, J. Meakins, F. Kemeny, et al.
Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis.
Gastroenterology, 98 (1990), pp. 733-738
[17.]
K.J. Paquet, P. Koussuris, M.A. Mercado, J. Kalk, D. Muting, W. Rambach.
La resección hepática limitada en pacientes cirróticos seleccionados con carcinoma hepatocelular o colangiocelular: un estudio prospectivo.
Br J Surg (ed. esp, 6 (1991), pp. 44-47
[18.]
M. Makuuchi, T. Takayama, K. Kubota, W. Kimura, Y. Midirikawa, S. Miyagawa, et al.
Hepatic resection for hepatocellular carcinoma. Japanese experience.
Hepatogastroenterol, 45 (1998), pp. 1267-1274
[19.]
J. Fuster, J.C. García Valdecasas, L. Grande, J. Tabet, J. Bruix, T. Anglada, et al.
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European Series.
Ann Surg, 223 (1996), pp. 297-302
[20.]
J. Balsells, R. Charco, J.L. Lazaro, E. Murio, V. Vargas, E. Allende, et al.
Resection of hepatocellular carcinoma in patients with cirrhosis.
Br J Surg, 83 (1996), pp. 758-761
[21.]
J. Santoyo, R. Marín, J.A. Bondia, M.A. Suárez, J.L. Fernández Aguilar, M. Jiménez, et al.
Resección quirúrgica del hepatocarcinoma. ¿Es éste el mejor tratamiento actual?.
Cir Esp, 67 (2000), pp. 123-128
[22.]
N. Nagasue, H. Kohno, M. Tachibana, A. Yamanoi, H. Ohmori, O. El Assa.
Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B-C cirrhosis.
Ann Surg, 229 (1999), pp. 84-90
[23.]
J.M. Reimbeau, O. Farges, S. Bai Yong, A. Sauvanet, J. Belghiti.
Is surgery for large hepatocellular carcinoma justified?.
J Hepatol, 31 (1999), pp. 1062-1068
[24.]
T. Utsonomiya, M. Shimada, K. Taguchi, H. Hasegawa, Y. Yamashita.
Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma.
J Am Coll Surg, 190 (2000), pp. 331-335
[25.]
Y. Fong, R. Sun, W. Jarnagin, L. Blumgart.
An analysis of 412 cases of hepatocellular carcinoma at a Western centre.
Ann Surg, 229 (1999), pp. 790-800
[26.]
R. Tung Ping-Poon, S.T. Fan, J. Wong.
Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma.
Ann Surg, 232 (2000), pp. 10-24
[27.]
J. Llovet, J. Bruix, J. Fuster, A. Castells, J.C. García Valdecasas, L. Grande, et al.
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
Hepatology, 27 (1998), pp. 1572-1577
[28.]
P.M. Rizzi, P.A. Kane, S.D. Ryder, J.K. Ramage, E. Gane, K.C. Tan, et al.
Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation.
Gastroenterology, 107 (1994), pp. 1425-1429
[29.]
R. Izumi, K. Shimizu, T. II, M. Yagi, O. Matsui, A. Nonomura, et al.
Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection.
Gastroenterology, 106 (1994), pp. 720-727
[30.]
M. Makuuchi, H. Hasegawa, Yamazaki.
Ultrasonically guided subsegmentectomy.
Surg Gynecol Obstet, 161 (1985), pp. 346-350
[31.]
E.L. McIntosh, G.Y. Minuk.
Hepatic resection in patients with cirrhosis and hepatocellular carcinoma.
Surg Gynecol Obstet, 174 (1992), pp. 245-254
[32.]
T. Nonami, A. Harada, T. Kurokawa, A. Nakao, H. Tagaki.
Hepatic resection for hepatocellular carcinoma.
Am J Surg, 173 (1997), pp. 288-291
[33.]
Y. Nakajima, T. Shimamura, T. Kamiyama, J. Kimura, N. Sato, M. Matsushita, et al.
Evaluation of surgical treatment for small hepatocellular carcinoma.
Am J Surg, 171 (1996), pp. 360-363
[34.]
D. Franco, G. Borgonovo.
Liver resection in cirrhosis of the liver.
[35.]
J. Santoyo, J.A. Bondia, M.A. Suárez, J.L. Fernández-Aguilar, R. Marín, M. Jiménez, et al.
Progresos técnicos en la cirugía hepática.
Cir Esp, 57 (1995), pp. 571-576
[36.]
S.T. Fan, C.L. Lo, C.M. Lam, W.K. Yuen, C. Yeung, J. Wong.
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.
Ann Surg, 229 (1999), pp. 322-330
[37.]
J. Belghiti, Y. Panis, J.P. Benhamou, F. Fekete.
Intrahepatic recurrence after resection of hepatocellular carcinoma.
Ann Surg, 214 (1991), pp. 114-117
[38.]
E. Adachi, T. Maeda, T. Matsumata, K. Shirabe, N. Kinukawa, K. Sugimachi, et al.
Gastroenterology, 108 (1995), pp. 768-775
[39.]
I. Nagashima, C. Hamada, K. Naruse, T. Osada, T. Nagao, N. Kawano, et al.
Surgical resection for small hepatocellular carcinoma.
Surgery, 119 (1996), pp. 40-45
[40.]
R. Tung Ping-Poon, S.T. Fan, C.M. Lo, C.L. Li, J. Wong.
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long term results of treatment and prognostic factors.
Ann Surg, 229 (1999), pp. 216-222
[41.]
H. Bismuth, P. Majno, R. Adam.
Liver transplantation for hepatocellular carcinoma.
Sem Liver Dis, 19 (1999), pp. 311-322
[42.]
S. Iwatsuki, T.E. Starzl, D. Sheahan, I. Yokoyama, A. Demetris, S. Todo, et al.
Hepatic resection vs transplantation for hepatocellular carcinoma.
Ann Surg, 214 (1991), pp. 221-229
[43.]
B. Ringe, R. Pichlmayr, C. Wittekind, G. Tusch.
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.
World J Surg, 15 (1991), pp. 270-285
[44.]
I. Penn.
Hepatic transplantation for primary and metastatic cancers of the liver.
Surgery, 110 (1991), pp. 726-734
[45.]
H. Bismuth, L. Chiche, R. Adam, D. Castaing, T. Diamond, A. Dennison.
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.
Ann Surg, 218 (1993), pp. 145-151
[46.]
F. Romani, L. Saverio, G.F. Rondinara, L. De Carlis, P. Rimoldi, F. Riolo, et al.
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
J Am Coll Surg, 178 (1994), pp. 379-384
[47.]
M. Schwartz, M. Sung, E. Mor, A. Fisher, I. Popescu, I. Fiel, et al.
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
J Am Coll Surg, 180 (1995), pp. 596-603
[48.]
V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, F. Bozzetti, et al.
Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis.
N Engl J Med, 334 (1996), pp. 693-699
[49.]
G. Colella, G.F. De Carlis, C.V. Rondinara, C.V. Sansalone, L.S. Belli, P. Aseni, et al.
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?.
Transpl Proc, 29 (1997), pp. 492-494
[50.]
J. Gugenheim, E. Baldini, M. Cassaccia, D. Ouzan, M.C. Saint Paul, J. Mouiel.
Résection et transplantation hépatique pour carcinome hepatocelulaire chez les malades atteins de cirrhose.
Gastroenterol Clin Biol, 21 (1997), pp. 590-595
[51.]
G. Otto, U. Heusschen, W. Hosfmann, G. Krumm, U. Hinz, C. Herfarrth.
Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma.
Ann Surg, 227 (1998), pp. 424-432
[52.]
J. Yamamoto, S. Iwasuki, T. Kosugue, I. Dvorchik, K. Shimada, W. Marsh, et al.
Should hepatomas be treated with hepatic resection or transplantation?.
Cancer, 86 (1999), pp. 1151-1158
[53.]
J.M. Llovet, J. Fuster, J. Bruix.
and BCLC group. Intention to treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.
Hepatology, 30 (1999), pp. 1434-1440
[54.]
J. Figueras, E. Jaurrieta, C. Valls, E. Ramos, T. Serrano, A. Rafecas, et al.
Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy.
J Am Coll Surg, 190 (2000), pp. 580-587
[55.]
J. Figueras, E. Jaurrieta, C. Valls, Bebasco, A. Rafecas, X. Xiol, et al.
Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
Hepatology, 25 (1997), pp. 1485-1489
[56.]
W. Marsh, I. Dvorchik, C.A. Bihnam, S. Iwatsuki.
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?.
Cancer, 88 (2000), pp. 538-543
[57.]
C. Valls, J. Figueras, E. Jaurrieta, C. Sancho, J. Domínguez, C. Benasco, et al.
Hepatocellular carcinoma: iodized oil-CT TNM classification.
[58.]
ELTR. Memoria 5/1968-12/1999.
[59.]
G.B. Klintmalm.
Liver transplantation for hepatocellular carcinoma. A registry report of the impact of tumor characteristics on outcome.
Ann Surg, 228 (1998), pp. 479-490
[60.]
E. Regalia, L.R. Fassati, U. Valente.
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation.
J Hepat Bil Pancr Surg, 5 (1998), pp. 29-34
[61.]
P. Magno, R. Adam, H. Bismuth, D. Castaing, A. Aricje, J. Krissat, et al.
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
Ann Surg, 226 (1997), pp. 688-703
[62.]
D. Harnois, J. Steers, J.C. Andrews, J. Rubin, H. Pitot, L. Burgart, et al.
Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.
Liver Transpl Surg, 5 (1999), pp. 192-199
[63.]
J. Bruix, BLCC group.
Radical treatment of hepatocellular carcinoma during the waiting list for orthotopic liver transplantation: a cost effectiveness analysis on an intention to treat basis.
Hepatology, 30 (1999), pp. A250
[64.]
P. Majno, F. Sarasin, G. Mentha, A. Hadengue.
Primary liver resection and salvage transplantation in patients with single, small, hepatoce- llular carcinoma and preserved liver function: an outcome oriented decision analysis.
Hepatology, 31 (2000), pp. 899-906
[65.]
P. Majno, R. Adam, V. Mazaferro, E. Regalia, G. Mentha, Morel, et al.
Liver transplantation for recurrence after resection of solitary hepatocellular carcinoma.
Liver Transpl Surg, (1999), pp. C18-S67
[66.]
F. Sarasin, E. Giostra, G. Mentha, A. Hadengue.
Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost efectivenesss perspective.
Hepatology, 28 (1998), pp. 436-442
Copyright © 2001. Asociación Española de Cirujanos
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos